170 unknown. 170 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 170 | Unknown 170 |
Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis HAVRIX - Cirrhosis, Hep A | Phase 4 | Unknown | Mahidol University | 50 | 2024-02-29 | 2024-03-19 |
| UHN Inpatient Hepatitis C & B Screening Quality Improvement - Hepatitis C, Hepatitis B | Phase 4 | Unknown | Jordan Feld | 2920 | 2024-02-01 | 2024-02-08 |
| Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. Hepatitis A Vaccine - Hepatitis A | Phase 4 | Unknown | Best Healthcare Inc. | 300 | 2024-01-01 | 2023-12-28 |
| Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir - Hepatitis C, Cirrhosis | Phase 4 | Unknown | Peking University People's Hospital | 100 | 2022-09-01 | 2022-07-21 |
| Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment Avatrombopag, Artificial Liver Support System, Comprehensive internal medical treatment. - Thrombocytopenia, Hepatitis B, Chronic | Phase 4 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 60 | 2022-04-27 | 2022-11-10 |
| HCV Treatment Initiation During Acute Psychiatric Admission HCV care provided by hospitalist during acute psychiatric admission - Hepatitis C | Phase 4 | Unknown | University Health Network, Toronto | 54 | 2022-04-19 | 2022-05-05 |
| Pharmacist-led Hepatitis C Management Pharmacist-Led care, Standard of Care (Hepatology) - Hepatitis C Virus Infection | Phase 4 | Unknown | University Health Network, Toronto | 108 | 2022-04-13 | 2022-04-27 |
| Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid), Sofosbuvir/Velpatasvir (Gilead) - Hepatitis C | Phase 4 | Unknown | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 1800 | 2022-03-09 | 2023-11-13 |
| The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students 20 µg dose hepatitis B vaccine - Hepatitis B Vaccine | Phase 4 | Unknown | Shanxi Medical University | 150 | 2022-02-20 | 2021-12-06 |
| Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy Mycophenolate Mofetil, Tacrolimus - Autoimmune Hepatitis | Phase 4 | Unknown | Leiden University Medical Center | 86 | 2022-01-19 | 2022-02-03 |
| Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin Cecolin, Hecolin - Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18 | Phase 4 | Unknown | Xiamen Innovax Biotech Co., Ltd | 480 | 2021-10-25 | 2022-06-13 |
| The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir - Chronic Hepatitis C, Chronic Hepatitis B | Phase 4 | Unknown | Peking University First Hospital | 120 | 2021-08-01 | 2021-08-09 |
| A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome Methylprednisolone and Mycophenolate mofetil, Methylprednisolone and azathioprine - Autoimmune Hepatitis, Primary Biliary Cirrhosis | Phase 4 | Unknown | Xiaoli Fan | 78 | 2021-06-16 | 2021-06-21 |
| Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy Cyclosporin A, Mycophenolate Mofetil - Hepatitis, Autoimmune, Primary Biliary Cholangitis | Phase 4 | Unknown | West China Hospital | 89 | 2021-06-16 | 2021-06-22 |
| Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides Tenofovir Alafenamide 25 MG - Hepatitis B, Chronic | Phase 4 | Unknown | New Discovery LLC | 100 | 2021-05-01 | 2020-11-17 |
| Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B Tenofovir Alafenamide fumarate 25mg Oral Tablet - Chronic Hepatitis B, Mother-to-Child Transmission | Phase 4 | Unknown | The First Affiliated Hospital of Zhengzhou University | 240 | 2021-04-26 | 2021-04-23 |
| Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF) antiviral prophylaxis with Tenofovir Alafenamide Fumarate - Hepatitis B, Chronic, Mother to Child Transmission | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 330 | 2021-04-04 | 2022-01-05 |
| Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 Ursodeoxycholic acid combined with total glucosides of paeony, Ursodeoxycholic acid only - Hepatitis, Primary Biliary Cholangitis | Phase 4 | Unknown | West China Hospital | 137 | 2021-03-17 | 2021-03-24 |
| Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) - Hepatitis, Autoimmune, Primary Biliary Cholangitis | Phase 4 | Unknown | West China Hospital | 90 | 2020-11-01 | 2021-03-22 |
| Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg - Hepatitis B, Chronic, Fibrosis, Liver | Phase 4 | Unknown | Seung Up Kim | 28 | 2020-09-18 | 2022-07-26 |
Showing 20 of 170. Sign in to see all of them.
Hepatitis B, Chronic (71) · Hepatitis B (55) · Hepatitis C (26) · Hepatitis C, Chronic (21) · Fibrosis (6) · Liver Cirrhosis (6) · Hepatitis, Autoimmune (5) · Carcinoma, Hepatocellular (4) · Hepatitis A (4) · Liver Cirrhosis, Biliary (4) · Coinfection (3) · Hepatitis, Alcoholic (3) · Liver Diseases, Alcoholic (3) · Acquired Immunodeficiency Syndrome (2)
Digestive System Diseases (169) · Liver Diseases (169) · Hepatitis, Viral, Human (156) · Infections (156) · Virus Diseases (156) · Blood-Borne Infections (151) · Communicable Diseases (151) · DNA Virus Infections (113) · Hepadnaviridae Infections (112) · Pathological Conditions, Signs and Symptoms (108) · Pathologic Processes (107) · Hepatitis, Chronic (96) · Disease Attributes (95) · Chronic Disease (93)
entecavir (36) · peginterferon alfa-2a (23) · Tenofovir (15) · Ribavirin (12) · Telbivudine (10) · Lamivudine (9) · adefovir (8) · tenofovir alafenamide (8) · adefovir dipivoxil (7) · sofosbuvir-velpatasvir drug combination (6) · Emtricitabine (5) · Mycophenolic Acid (5) · Sofosbuvir (5) · peginterferon alfa-2b (5) · velpatasvir (5)
National Taiwan University Hospital (11) · Third Affiliated Hospital, Sun Yat-Sen University (8) · Nanfang Hospital, Southern Medical University (6) · Asian-Pacific Alliance of Liver Disease, Beijing (5) · Beijing Ditan Hospital (5) · Yonsei University (5) · Beijing 302 Hospital (4) · Shanxi Medical University (4) · University Health Network, Toronto (4) · West China Hospital (4) · Kaohsiung Medical University Chung-Ho Memorial Hospital (3) · Ruijin Hospital (3) · Asan Medical Center (2) · IlDong Pharmaceutical Co Ltd (2) · Instituto de Investigación Marqués de Valdecilla (2)
China (61) · Taiwan (19) · South Korea (15) · United States (8) · Canada (6) · Egypt (4) · Spain (4) · India (3) · Italy (3) · Netherlands (3) · Thailand (3) · Belgium (2) · Australia (1) · Austria (1) · Brazil (1)
Jun Cheng, M.D. (5) · Pei-Jer Chen, M.D., Ph.D. (3) · Suping Wang, PhD (3) · Alejandro Soza, MD (2) · Calvin Q Pan, MD (2) · Chen-Hua Liu, MD (2) · Cheng-Chao Liang, MD (2) · Chih-Lin Lin, MD (2) · Ching-Sheng Hsu, MD (2) · Gamal Esmat, MD (2) · Jia-Horng Kao, MD, PhD (2) · Jinlin Hou (2) · Jinlin Hou, MD (2)
PMID 19187608, PMID 21182232, PMID 22436845, PMID 23046671, PMID 23518903, PMID 24915612, PMID 25348661, PMID 42349783, PMID 10051494, PMID 10613747, PMID 11855555, PMID 12019083, PMID 12606735, PMID 14697813, PMID 15014185, PMID 15470215, PMID 15985009, PMID 15987917, PMID 16164651, PMID 16525137, PMID 16708058, PMID 17377504, PMID 18094378, PMID 19027013, PMID 19052126, PMID 19376603, PMID 19729084, PMID 20049753, PMID 20220333, PMID 2023605, PMID 20377423, PMID 2142748, PMID 21677438, PMID 21701902, PMID 22045673, PMID 22273662, PMID 22371643, PMID 23150796, PMID 23219442, PMID 23245604, PMID 23449768, PMID 23689577, PMID 24189358, PMID 24375637, PMID 24583931, PMID 24843060, PMID 24954675, PMID 25190434, PMID 25381721, PMID 25643863
2005 (1)